Also from this source

You just read:

New Preclinical Data Confirm Naurex's Novel Antidepressant GLYX-13 Appears Free of the Behavioral Impairment and Abuse Potential Seen With Ketamine

News provided by

Naurex Inc.

Dec 07, 2010, 07:30 EST